CD79A and plasma cell myeloma: Most patients were diagnosed with myeloma of the immunoglobulin (Ig)G subtype (69.0%), followed by IgA (16.2%) and light chains (10.2%), IgM (2.0%), IgD (1.0%), and biclonal type (0.5%).